News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

Ed Ikeguchi, MD

Advertisement

CEO of AiCure

Articles by Ed Ikeguchi, MD

Tackling Trial Diversity Through Higher Innovation Standards

ByEd Ikeguchi, MD
March 3rd 2023

Advancing responsible AI innovation to help resolve patient disparities.

The Defining AI Trends of 2022

ByEd Ikeguchi, MD
January 6th 2022

The full potential of artificial intelligence is still yet to be realized.

Advertisement

Latest Updated Articles

  • The Defining AI Trends of 2022
    The Defining AI Trends of 2022

    Published: January 6th 2022 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Life Sciences Can’t Afford Fragmented Data and Disconnected Teams

2

FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data

3

What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation

4

ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA

5

Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us